A Study to Assess the Relative Bioavailability of Different Subcutaneous Formulations ofAZD6234
Clinical trial NCT07220954 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT07220954
- Sponsor
- AstraZeneca
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-11-11
- Primary completion
- 2026-09-17
- Enrollment
- 19
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.